{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:36:02Z","timestamp":1787150162437,"version":"build-2736575974"},"reference-count":10,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"unspecified","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,8,8]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Interstitial lung abnormalities (ILAs) are an important incidental finding in lung screening. Quantitative CT (qCT) offers a promising approach to standardising ILA assessment; however, its adoption into routine clinical practice remains limited, largely due to the need for further clinical validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>We evaluated the performance of e-Lung (Brainomix), a commercially available qCT tool in assessing ILAs for participants attending a lung cancer screening programme.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>All participants invited to attend the West London lung cancer screening pilot programme between 2018 and 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary outcome measures<\/jats:title>\n                    <jats:p>To define the optimal qCT biomarker thresholds that identified ILA as defined by expert thoracic radiologists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>e-Lung qCT biomarkers had an area under the curve of between 0.82 and 0.88, and between 0.84 and 0.87 for visually quantified ILA extent thresholds of at least 5% and &gt;10%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>e-Lung is a qCT tool with potential utility in the automated identification of ILA in participants undergoing lung screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003974","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:20:22Z","timestamp":1787149222000},"page":"e003974","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Automated identification of interstitial lung abnormalities in lung screening using quantitative CT"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3623-0487","authenticated-orcid":false,"given":"Niamh","family":"Logan","sequence":"first","affiliation":[{"name":"Royal Brompton and Harefield Hospitals, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujal R","family":"Desai","sequence":"additional","affiliation":[{"name":"Royal Brompton and Harefield Hospitals, London, UK"},{"name":"National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Royal Brompton and Harefield Hospitals, London, UK"},{"name":"National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hewitt","sequence":"additional","affiliation":[{"name":"Royal Brompton and Harefield Hospitals, London, UK"},{"name":"King\u2019s Centre for Lung Health, School of Immunology & Microbial Sciences, King's College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1316-4891","authenticated-orcid":false,"given":"Peter M","family":"George","sequence":"additional","affiliation":[{"name":"Royal Brompton and Harefield Hospitals, London, UK"},{"name":"National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Devaraj","sequence":"additional","affiliation":[{"name":"Royal Brompton and Harefield Hospitals, London, UK"},{"name":"National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"2026081907201393000_13.1.e003974.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202505-1054ST"},{"key":"2026081907201393000_13.1.e003974.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0518"},{"key":"2026081907201393000_13.1.e003974.3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1164\/rccm.202302-0271OC","article-title":"Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis","volume":"208","author":"Grant-Orser","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026081907201393000_13.1.e003974.4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201109-1618OC"},{"key":"2026081907201393000_13.1.e003974.5","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233435","article-title":"Automated Interstitial Lung Abnormality Probability Prediction at CT: A Stepwise Machine Learning Approach in the Boston Lung Cancer Study","volume":"312","author":"Hata","year":"2024","journal-title":"Radiology"},{"key":"2026081907201393000_13.1.e003974.6","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00570-2024","article-title":"Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis","volume":"10","author":"George","year":"2024","journal-title":"ERJ Open Res"},{"key":"2026081907201393000_13.1.e003974.7","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A7678","article-title":"Effect of Nintedanib on Quantitative CT in Patients With Progressive Pulmonary Fibrosis: Results from the INBUILD Trial","volume":"211","author":"Devaraj","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026081907201393000_13.1.e003974.8","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.01058-2025","article-title":"e-Lung computed tomography biomarkers are associated with outcomes in fibrotic interstitial lung diseases","volume":"12","author":"Abbasi Dezfouli","year":"2026","journal-title":"ERJ Open Res"},{"key":"2026081907201393000_13.1.e003974.9","first-page":"S26","article-title":"A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients","volume":"28","author":"Kim","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2026081907201393000_13.1.e003974.10","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.202312-2274LE","article-title":"e-Lung Computed Tomography Biomarker Stratifies Patients at Risk of Idiopathic Pulmonary Fibrosis Progression in a 52-Week Clinical Trial","volume":"209","author":"Devaraj","year":"2024","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003974","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:20:23Z","timestamp":1787149223000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,8,19]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjresp-2025-003974"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003974","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}